140 related articles for article (PubMed ID: 1346710)
1. c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder.
Lunec J; Challen C; Wright C; Mellon K; Neal DE
Lancet; 1992 Feb; 339(8790):439-40. PubMed ID: 1346710
[No Abstract] [Full Text] [Related]
2. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification.
Habuchi T; Kinoshita H; Yamada H; Kakehi Y; Ogawa O; Wu WJ; Takahashi R; Sugiyama T; Yoshida O
J Natl Cancer Inst; 1994 Sep; 86(17):1331-5. PubMed ID: 8064891
[TBL] [Abstract][Full Text] [Related]
3. Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
Coombs LM; Pigott DA; Sweeney E; Proctor AJ; Eydmann ME; Parkinson C; Knowles MA
Br J Cancer; 1991 Apr; 63(4):601-8. PubMed ID: 1673627
[TBL] [Abstract][Full Text] [Related]
4. p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas.
Goto K; Konomoto T; Hayashi K; Kinukawa N; Naito S; Kumazawa J; Tsuneyoshi M
Mod Pathol; 1997 May; 10(5):428-37. PubMed ID: 9160306
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of MDM-2 mRNA and mutation of the p53 tumor suppressor gene in bladder carcinoma cell lines.
Cheng YT; Li YL; Wu JD; Long SB; Tzai TS; Tzeng CC; Lai MD
Mol Carcinog; 1995 Jul; 13(3):173-81. PubMed ID: 7619220
[TBL] [Abstract][Full Text] [Related]
6. [Detection and clinical pathological significance of the expression of P21, P185, p53 proteins and mutation of ras, p53 genes in transitional cell carcinoma of the bladder].
Yu D; Liu F; Liang Z
Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):202-5. PubMed ID: 9275651
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the p53 gene in carcinomas of the urinary system.
Suzuki Y; Tamura G
Acta Pathol Jpn; 1993 Dec; 43(12):745-50. PubMed ID: 8109252
[TBL] [Abstract][Full Text] [Related]
8. Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer.
Zhau HE; Zhang X; von Eschenbach AC; Scorsone K; Babaian RJ; Ro JY; Hung MC
Mol Carcinog; 1990; 3(5):254-7. PubMed ID: 1978777
[TBL] [Abstract][Full Text] [Related]
9. [int-2 and c-erbB-2 gene amplification in urological cancers].
Sato K; Kato T; Moriyama M
Nihon Hinyokika Gakkai Zasshi; 1992 Dec; 83(12):1957-63. PubMed ID: 1361954
[TBL] [Abstract][Full Text] [Related]
10. An immunohistological demonstration of c-erbB-2 oncoprotein expression in primary urothelial bladder cancer.
Gardiner RA; Samaratunga ML; Walsh MD; Seymour GJ; Lavin MF
Urol Res; 1992; 20(2):117-20. PubMed ID: 1348155
[TBL] [Abstract][Full Text] [Related]
11. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
Wright C; Mellon K; Johnston P; Lane DP; Harris AL; Horne CH; Neal DE
Br J Cancer; 1991 Jun; 63(6):967-70. PubMed ID: 1712624
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the expression of oncogenes ras and c-erbB-2 and the biological behavior of bladder tumors.
Ye DW; Zheng JF; Qian SX; Ma YJ
Urol Res; 1993 Jan; 21(1):39-43. PubMed ID: 8096102
[TBL] [Abstract][Full Text] [Related]
13. bcl-2/bax expression and p53 gene status in human bladder cancer: relationship to early recurrence with intravesical chemotherapy after resection.
Ye D; Li H; Qian S; Sun Y; Zheng J; Ma Y
J Urol; 1998 Dec; 160(6 Pt 1):2025-8; discussion 2029. PubMed ID: 9817315
[TBL] [Abstract][Full Text] [Related]
14. Absence of frameshift mutations in the bax gene in renal cell cancer (RCC) and transitional cell cancer (TCC).
Bilim VN; Kawasaki T; Takahashi K; Tomita Y
Anticancer Res; 1998; 18(3A):1655-9. PubMed ID: 9673385
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetics of human bladder carcinomas.
Perucca D; Szepetowski P; Simon MP; Gaudray P
Cancer Genet Cytogenet; 1990 Oct; 49(2):143-56. PubMed ID: 2208052
[TBL] [Abstract][Full Text] [Related]
16. p53 mutations and MDM-2 amplification in renal cell cancers.
Imai Y; Strohmeyer TG; Fleischhacker M; Slamon DJ; Koeffler HP
Mod Pathol; 1994 Sep; 7(7):766-70. PubMed ID: 7824511
[TBL] [Abstract][Full Text] [Related]
17. [Gene sequence analysis of suppressor oncogene p53 in bladder carcinoma].
Rosell Costa D; García-Foncillas Lopez J; Díez-Caballero Vivas-Pérez JI; Garcia-Tapia JA; Sanz Pérez G; Abad Alonso FD; Martín-Marquina Aspiunza A; Rodríguez-Rubio Cortadellas FI; Robles García JE; Zudaire Bergera JJ; Berián Polo JM
Actas Urol Esp; 1998; 22(7):552-6. PubMed ID: 9807864
[TBL] [Abstract][Full Text] [Related]
18. [p53 mutation in phenacetin-induced urothelial carcinomas].
Petersen I; Ohgaki H; Ludeke BI; Kleihues P
Verh Dtsch Ges Pathol; 1993; 77():252-5. PubMed ID: 7511292
[TBL] [Abstract][Full Text] [Related]
19. [Gene p53 mutation and prognosis in bladder tumors].
Polito M; Minardi D; Giannulis I; Montironi R; Yehia M; Cristalli AF; Muzzonigro G
Arch Ital Urol Androl; 1997 Feb; 69 Suppl 1():65-8. PubMed ID: 9181926
[TBL] [Abstract][Full Text] [Related]
20. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]